FDA Consulting Services: Strategy, Submissions & Compliance
Bringing a regulated product to market takes careful planning. A missing document, weak filing, or compliance gap can delay your launch and create more work for your team. FDA requirements can also change, making it difficult to keep your regulatory strategy current. XFDA Pharma Advisors provides FDA consulting services to help companies manage these challenges. Our team includes former FDA staff with hands-on experience across submissions, compliance, inspections, and regulatory reviews.
Whether you are preparing a new filing or dealing with an existing FDA issue, we help you understand the requirements and plan the right next steps. Our focus is practical guidance that keeps your project moving without adding unnecessary complexity.
Why Companies Trust Our FDA Consulting Services
FDA requirements can look very different from one product to another. A first-time filer may need help choosing a regulatory pathway, while an established company may need support with a quality system or FDA inspection.
XFDA Pharma Advisors looks at your product, current systems, and regulatory goals before recommending a course of action. We review key documents and procedures, looking for issues that could surface down the road. Our FDA consulting services focus on giving your team direction at every step, so you always know what needs attention, what can wait, and what to tackle next.
Our Services
FDA & Pharmaceutical Compliance Consulting Services
XFDA Pharma Advisors provides specialized FDA consulting and pharmaceutical compliance services to pharmaceutical, biopharmaceutical, API, OTC, sterile manufacturing, and CMO/CDMO organizations in the United States and globally.
Our team of former FDA professionals and senior pharmaceutical industry experts provides hands-on support for FDA inspection readiness, CGMP compliance, regulatory remediation, laboratory operations, data integrity, quality systems, and complex manufacturing compliance challenges.
Whether you are preparing for an FDA inspection, responding to regulatory observations, addressing significant compliance deficiencies, or strengthening your Pharmaceutical Quality System, we provide practical, risk-based solutions designed to achieve and maintain a state of control.
FDA Inspection Readiness & Mock FDA Inspections
Prepare your facility, systems, documentation, and personnel before FDA arrives.
XFDA Pharma Advisors conducts mock FDA inspections and FDA inspection readiness assessments for Pre-Approval Inspections (PAIs), surveillance inspections, and other FDA inspections.
Our support includes FDA six-system assessments, facility and laboratory walkthroughs, document readiness, front-room and back-room preparation, SME interview coaching, inspection simulations, and identification of potential CGMP deficiencies.
FDA 483 Response Consulting
Received a Form FDA 483? XFDA Pharma Advisors helps organizations evaluate FDA observations, determine root causes and systemic impact, develop appropriate CAPAs, and prepare comprehensive responses supported by credible remediation plans and
evidence.
Our support includes 483 response development, root cause analysis, retrospective review strategies, CAPA development, remediation planning, effectiveness verification, and FDA follow-up inspection readiness.
FDA Warning Letter Remediation
XFDA Pharma Advisors provides comprehensive FDA Warning Letter response and remediation support for organizations facing significant CGMP and regulatory compliance issues.
Our former FDA and industry experts assist with comprehensive gap assessments, root cause investigations, systemic impact evaluations, CAPA development, retrospective reviews, data integrity remediation, quality-system remediation, FDA meeting preparation, and reinspection readiness.
FDA Pre-Approval Inspection (PAI) Readiness
Our PAI readiness consultants help pharmaceutical manufacturers prepare their facilities, systems, data, documentation, and personnel for FDA Pre-Approval Inspections.
Assessments may include CMC-to-site verification, process validation, analytical method readiness, laboratory controls, stability programs, batch records, data integrity, equipment qualification, quality systems, and employee interview preparation.
Pharmaceutical Data Integrity Consulting
XFDA Pharma Advisors performs comprehensive pharmaceutical data integrity assessments and remediation across laboratory, manufacturing, quality, and computerized systems.
Our assessments cover ALCOA+ principles, audit trails, user access, electronic records, chromatography systems, standalone equipment, spreadsheets, backup and restoration, data governance, retrospective reviews, and data integrity investigations.
Pharmaceutical Laboratory Compliance
Our pharmaceutical laboratory compliance consultants assess QC chemistry and microbiology operations from both scientific and FDA CGMP perspectives.
Areas of focus include OOS/OOT investigations, laboratory incidents, chromatography systems, audit trails, analytical method validation and verification, system suitability, stability programs, reference standards, equipment qualification, analyst training, electronic records, and laboratory data integrity.
CGMP & Pharmaceutical Quality Systems
XFDA Pharma Advisors helps organizations assess, strengthen, and remediate their Pharmaceutical Quality Systems and CGMP compliance programs.
Our expertise includes Quality Unit oversight, deviations, investigations, CAPA, change control, complaints, APR/PQR, quality risk management, training, document control, batch record review, internal audits, quality metrics, and management oversight.
Sterile Manufacturing & Aseptic Processing
Our sterile GMP consultants support sterile drug manufacturers with aseptic processing, contamination control, environmental monitoring, media fills, personnel qualification, gowning, cleaning and disinfection, cleanroom controls, microbiology systems, utilities, pharmaceutical water systems, and sterility assurance.
We also support FDA inspection readiness and EU GMP Annex 1 / Contamination Control Strategy (CCS) assessments.
API Manufacturing & ICH Q7 Compliance
XFDA Pharma Advisors provides API GMP consulting, ICH Q7 assessments, and FDA inspection readiness support for active pharmaceutical ingredient manufacturers.
Our assessments cover starting materials, raw materials, manufacturing controls, laboratory operations, analytical methods, impurities, process validation, cleaning, crosscontamination, investigations, CAPA, data integrity, supplier qualification, and quality oversight.
CMO/CDMO Audits & Supplier Qualification
Effective outsourcing requires effective quality oversight.
XFDA Pharma Advisors conducts CMO/CDMO audits, pharmaceutical supplier qualification audits, and independent GMP assessments to help organizations evaluate and oversee contract manufacturers, laboratories, and critical suppliers.
Our support includes qualification and requalification audits, quality agreement reviews, investigation and CAPA assessments, laboratory oversight, quality-system assessments, and regulatory inspection readiness.
CMC & Regulatory Compliance Support
Our experts provide compliance-focused CMC consulting and regulatory documentation support, including Module 3 reviews, manufacturing process documentation, specifications, analytical procedures, method validation and verification, stability, process validation, and raw material controls.
A key focus is identifying potential gaps between regulatory commitments and actual manufacturing, laboratory, and quality-system practices before they become regulatory issues.
Pharmaceutical Validation & Qualification
XFDA Pharma Advisors provides independent pharmaceutical validation and qualification consulting covering process validation, cleaning validation, equipment qualification, IQ/OQ/PQ, computerized system validation, laboratory equipment, facilities, utilities, and Continued Process Verification.
We evaluate whether programs are scientifically justified, appropriately documented, and capable of demonstrating a continued state of control.
Independent Remediation & Quality Oversight
For organizations undergoing significant regulatory or CGMP remediation, XFDA Pharma Advisors provides independent remediation and quality oversight from initial assessment through effectiveness verification.
Support may include CAPA oversight, retrospective reviews, investigation assessments, batch and laboratory record reviews, quality-system remediation, periodic effectiveness assessments, management reporting, and FDA reinspection readiness.
FDA Inspection Training & Coaching
Prepare your people—not just your documents.
XFDA Pharma Advisors provides customized FDA inspection training and coaching for executives, Quality Unit personnel, manufacturing teams, laboratory personnel, SMEs, and inspection support teams.
Training includes FDA investigator interactions, SME interview preparation, inspection behavior, front-room and back-room operations, document request management, data integrity, OOS investigations, CAPA, laboratory compliance, and Good Documentation Practices.
Need FDA Compliance Support?
Whether you are preparing for an upcoming FDA inspection or PAI, responding to a Form FDA 483 or Warning Letter, addressing data integrity concerns, or managing a complex CGMP remediation, our team is ready to help.
Talk With a Former FDA Consultant
Schedule a confidential consultation with XFDA Pharma Advisors to discuss your FDA compliance and inspection-readiness needs.
Why Choose XFDA Pharma Advisors?
Former FDA Experience. Senior Industry Expertise. Hands-On Support.
XFDA Pharma Advisors brings together former FDA professionals and senior pharmaceutical industry experts with extensive experience in FDA inspections, pharmaceutical manufacturing, laboratory operations, quality systems, data integrity, and complex regulatory remediation.
We don’t simply identify compliance gaps. We help organizations understand why the gap exists, its potential regulatory significance, what needs to be corrected, and how to demonstrate that corrective actions are sustainable and effective.
From FDA inspection readiness and mock FDA inspections to 483 responses, Warning Letter remediation, PAI readiness, data integrity, laboratory compliance, and independent remediation oversight, XFDA Pharma Advisors provides practical support throughout the compliance lifecycle.
How We Work With You
A Practical, Risk-Based Approach to FDA Compliance.
Every engagement begins with understanding your specific regulatory and compliance needs. Whether you are preparing for an FDA inspection, addressing Form FDA 483 observations or a Warning Letter, strengthening your quality systems, or preparing for a PreApproval Inspection (PAI), XFDA Pharma Advisors provides a structured, risk-based approach tailored to your operation.
Step 1: Initial Consultation
We begin with an introductory consultation to understand your facility, products, regulatory status, current challenges, and objectives. This discussion allows us to identify your immediate priorities and determine the appropriate scope of support.
Step 2: Assessment & Gap Analysis
Our experts evaluate the relevant systems, procedures, records, and regulatory documentation against applicable FDA requirements and industry expectations. Depending on the engagement, this may include a comprehensive CGMP assessment, mock FDA inspection, laboratory or data integrity assessment, quality-system review, inspection-readiness assessment, or targeted review of a specific compliance concern. The objective is not simply to identify gaps, but to determine their significance and prioritize the areas requiring attention.
Step 3: Compliance Strategy & Remediation Roadmap
Based on our findings, we develop a practical roadmap that defines priorities, recommended corrective actions, responsibilities, and next steps. For remediation projects, we help your team address root causes and develop sustainable CAPAs rather than relying on short-term corrections. For inspection-readiness engagements, we focus resources on the systems and activities most likely to receive regulatory scrutiny
Step 4: Implementation & Hands-On Support
Our consultants work directly with your team to implement the agreed strategy. Support may include procedure development and revision, CAPA remediation, investigation review, data integrity improvements, quality-system enhancements, inspection preparation, frontroom and back-room coaching, CMC documentation review, and preparation of regulatory responses. Our approach is collaborative and practical, with solutions designed to work within your actual operations—not just on paper.
Step 5: Verification & Inspection Readiness
Before the engagement is completed, we evaluate whether key corrective actions and improvements have been effectively implemented. When FDA inspection readiness is the objective, this may include follow-up assessments, mock interviews, document challenges, facility walkthroughs, inspection simulations, and verification of supporting evidence.
Step 6: Ongoing Regulatory & Compliance Support
FDA compliance does not end when an audit or remediation project is completed. XFDA Pharma Advisors can continue supporting your organization through FDA inspections, regulatory responses, CAPA effectiveness verification, quality-system improvements, CMO/CDMO oversight, and evolving compliance needs.
From identifying the problem to implementing and verifying the solution, XFDA Pharma Advisors provides experienced, hands-on support throughout the FDA compliance lifecycle.
Staying Ahead of Recent FDA Changes
FDA requirements continue to evolve. Keeping up with these changes is important for firms that want to avoid compliance gaps.
The agency is moving from the old QSR framework to the new QMSR. This brings US device quality requirements closer to the global ISO 13485 framework. Device makers need to review their systems and update them where needed.
ew regulatory questions also involve AI and software as a medical devic. Your FDA regulatory consultant can help you organize the right information and present your data clearly.
Food firms also face changing FSMA requirements around tracking, records, and food safety controls. Our FDA compliance services help teams understand these needs and keep their processes current.
XFDA Pharma Advisors helps clients stay aware of important regulatory changes throughout the year.
Industries We Serve
Specialized FDA & CGMP Consulting Across Pharmaceutical and Life Sciences Manufacturing.
XFDA Pharma Advisors supports pharmaceutical, biopharmaceutical, and regulated product manufacturers with practical, inspection-focused compliance solutions. Our team of former FDA investigators, compliance professionals, and senior industry experts brings extensive experience in FDA inspections, CGMP compliance, quality systems, laboratory operations, data integrity, and regulatory remediation. Our experience includes:
Prescription Pharmaceuticals
Brand and generic drug manufacturers, including NDA and ANDA products.
Active Pharmaceutical Ingredients (APIs)
API and intermediate manufacturers operating under FDA CGMP and ICH Q7 expectations.
Sterile & Aseptic Products
Sterile drug products, aseptic processing operations, contamination control, and microbiological systems.
Biologics & Biopharmaceuticals
Quality systems, manufacturing controls, laboratory operations, and FDA inspection readiness.
Over-the-Counter (OTC) Drugs
OTC drug manufacturing, testing, packaging, quality systems, and FDA CGMP compliance.
Contract Manufacturers & CDMOs/CMOs
FDA inspection readiness, qualitysystem assessments, client oversight, supplier qualification, and remediation support.
Pharmaceutical Laboratories
QC chemistry and microbiology laboratories, data integrity, OOS/OOT investigations, method validation/verification, and laboratory controls.
Drug-Device Combination Products
CGMP and quality-system support for pharmaceutical operations involving combination products.
Transdermal & Drug-Delivery Products
Manufacturing, laboratory, cleaning, cross-contamination, and quality-system controls.
Cosmetics & Personal Care Products
FDA compliance and MoCRA readiness, including quality systems, manufacturing controls, and facility preparedness.
Whether preparing for an FDA Pre-Approval Inspection (PAI), surveillance inspection, responding to a Form FDA 483 or Warning Letter, addressing data-integrity concerns, or strengthening an existing Pharmaceutical Quality System, XFDA Pharma Advisors provides hands-on support based on real FDA and industry experience.
Move Your Product Forward with the Right FDA Support
You do not have to manage the FDA process alone. The right regulatory support can help you make informed decisions, avoid preventable delays, and stay prepared as requirements change.
XFDA Pharma Advisors provides practical FDA consulting services for companies at different stages of the product life cycle. Whether you need help with a submission, quality system, FDA response, inspection, or ongoing compliance, our team can support you through the process.
Ready to take the next step? Reach out today for a free call. Tell us about your product, current stage, and main goal. We can help you understand what comes next and build a clear path toward market access and ongoing compliance.
Frequently Asked Questions
An FDA consultant helps you deal with the regulatory side of your product. That may mean reviewing a submission, preparing for an inspection, answering FDA questions, or fixing a compliance issue. They can also point out problems your team may not have noticed before filing or during a review.
YFDA consulting fees are not the same for every project. A quick document review will cost less than support for a full submission or a major compliance issue. Some consultants bill by the hour. Others charge a set project fee or a monthly retainer. The best option usually comes down to the work involved and how much support you need.
There is no standard timeline. Some work can be finished in a few weeks. Larger projects may take several months, especially when documents, data, or other teams are involved. Before you start, your FDA regulatory consultant should give you a realistic idea of how long the work is likely to take.
You can handle some FDA work with an experienced in-house team. But things can get complicated when you are dealing with a new filing, an inspection, or a response to the FDA. If your team is unsure about the requirements or does not handle this work often, bringing in an FDA consultant can save time and help prevent avoidable mistakes.
Yes. We can review the FDA's findings and help your team work through the response. That includes preparing the written response and looking at the corrective actions needed to address the issues. If you already have a 483 or Warning Letter, it is better to deal with it early rather than let the response sit.
We use all three. For a specific filing or one-time review, a project fee may be the better choice. Hourly work can make sense when you only need help with certain tasks. If you expect to need regulatory support on a regular basis, a retainer gives you ongoing access to our team.